Together we will beat cancer


First treatment approved in England for advanced bile duct cancer

The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.

Read More

‘A significant step forwards’ – treating patients with advanced biliary tract cancers

An existing combination of chemotherapy could be used to provide a new option for biliary tract cancer patients.

Read More

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug.

Read More

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.

Read More

Making a impact in rarer cancers – the ABC02 trial

Finding new treatments for rare and hard-to-treat cancers is one of our greatest challenges. The best way of testing out…

Read More